Characteristic | Total | Germline MMR gene mutation | IHC MMR protein | MSI | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Absence | Presence | p value | Intact | Deficient | p value | Negative | Positive | p value | ||
Total (cases) | 111 | 105 | 6 | Â | 74 | 28 | Â | 71 | 12 | Â |
Age (years; median [range]) |  | 56.00 (31–82) | 54.00 (48–57) | 0.440 | 56.50 (32–82) | 53.50 (31–73) | 0.102 | 57.00 (32–82) | 55.00 (40–73) | 0.658 |
Gravidity [median (range)] |  | 2 (0–7) | 2 (0–5) | 0.374 | 2 (0–5) | 2 (0–7) | 0.437 | 2 (0–7) | 2 (0–5) | 0.020 |
Parity (median, range) |  | 1 (0–4) | 1 (0–2) | 0.779 | 1 (0–4) | 1 (0–2) | 0.498 | 1 (0–4) | 1 (0–3) | 0.189 |
BMI (kg/m2; median [range]) |  | 24.98 (19–32) | 21.60 (19–23) | 0.010 | 25.66 (19–32) | 24.27 (20–32) | 0.622 | 24.98 (19–32) | 23.87 (19–31) | 0.343 |
Involvement of the lower uterine segment [cases (%)] | 27 | 24 (22.9) | 3 (50.0) | 0.132 | 17 (23.0) | 9 (32.1) | 0.343 | 14 (19.7) | 4 (33.3) | 0.290 |
Type of EC [cases (%)] | Â | Â | Â | 0.189 | Â | Â | 0.983 | Â | Â | 0.937 |
 Type I | 87 | 81 (77.1) | 6 (100.0) |  | 58 (78.4) | 22 (78.6) |  | 54 (76.1) | 9 (75.0) |  |
 Type IIa | 24 | 24 (22.9) | 0 (0) |  | 16 (21.6) | 6 (21.4) |  | 17 (23.9) | 3 (25.0) |  |
FIGO stage [cases (%)]b | Â | Â | Â | 0.012 | Â | Â | 0.266 | Â | Â | 0.354 |
 FIGO I | 87 | 85 (81.0) | 2 (33.3) |  | 61 (82.4) | 19 (67.9) |  | 60 (84.5) | 9 (75.0) |  |
 FIGO III | 19 | 15 (14.3) | 4 (66.7) |  | 11 (14.9) | 8 (28.6) |  | 8 (11.3) | 3 (25.0) |  |
 FIGO IV | 4 | 4 (3.8) | 0 (0) |  | 2 (2.7) | 1 (3.6) |  | 3 (4.2) | 0 (0) |  |
 Unknown | 1 | 1 (1.0) | 0 (0) |  | 0 (0) | 0 (0) |  | 0 (0) | 0 (0) |  |